Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
AGCU ScienTech is a leading biotechnology company specializing in the development, production, and sale of DNA identification and molecular diagnostic products. Headquartered in Wuxi, China, the company focuses on providing comprehensive solutions for forensic science, paternity testing, and clinical genetics. Their core technology revolves around multiplex PCR and fluorescence labeling, enabling the simultaneous detection of multiple genetic markers. The company's product line includes a variety of Short Tandem Repeat (STR) kits and automated capillary electrophoresis genetic analyzers. AGCU ScienTech serves a global market, providing tools for law enforcement, judicial expertise, and medical research. By integrating advanced genomics with automated platforms, the company aims to enhance the efficiency and accuracy of human identification and genetic screening.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on AGCU ScienTech.